How to critically appraise a clinical trial

  • L. R. Sutherland


The prescription of medications is a daily activity for most physicians. The act of prescribing incorporates a number of factors including issues related to effectiveness, appropriate use, comparability with other medications, adverse events and cost. The answers to most of these issues can be found within the body of the available medical literature. But therein lies a dilemma. Clinicians wish to base their therapeutic decisions on scientific data but are often overwhelmed by the number of case reports, open series and other therapeutic trials that are published each year.


Inflammatory Bowel Disease Ulcerative Colitis Active Medication Pill Count Open Series 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Department of Clinical Epidemiology and Biostatistics, McMaster University Health Sciences Centre. How to read medical journals: V. To distinguish useful from useless or even harmful therapy. CMAJ. 1981; 124: 1156–62.Google Scholar
  2. 2.
    Meinert CL. Clinical trials design conduct, and analysis. Oxford: Oxford University Press; 1986.Google Scholar
  3. 3.
    Courtney MG, Nunes DP, Bergin CF et al. Randomised comparison of olsalazine and mesalazine in prevention of relapses in ulcerative colitis. Lancet. 1992; 339: 1279–81.PubMedCrossRefGoogle Scholar
  4. 4.
    Caprilli R, Andreoli A, Capurso L et al. Oral mesalazine (5-aminosalicylic acid: Asacol) for the prevention of post-operative recurrence of Crohn’s disease. Aliment Pharmacol Ther. 1994; 8: 35–43.PubMedCrossRefGoogle Scholar
  5. 5.
    Sutherland LR. Editorial: 5-aminosalicylates for prevention of recurrence in patients with Crohn’s disease: Time for a reappraisal? J Clin Gastroenterol. 1991; 13: 5–7.PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers and Axcan Pharma, Inc. 1994

Authors and Affiliations

  • L. R. Sutherland

There are no affiliations available

Personalised recommendations